VioQuest Pharmaceuticals, Inc. (VOQP)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2007 | -10.89 Million USD | -31.68% |
| 2006 | -8.27 Million USD | 35.56% |
| 2005 | -12.83 Million USD | -218.99% |
| 2004 | -4.02 Million USD | -99.34% |
| 2003 | -2.01 Million USD | -3790.29% |
| 2002 | -51.88 Thousand USD | 73.81% |
| 2001 | -198.08 Thousand USD | -15.77% |
| 2000 | -171.1 Thousand USD | -491.08% |
| 1999 | 43.75 Thousand USD | 2376.0% |
| 1998 | 1767.00 USD | 102.53% |
| 1997 | -69.92 Thousand USD | -286.23% |
| 1996 | -18.1 Thousand USD | -2169.14% |
| 1995 | 875.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2008 Q1 | -3.08 Million USD | -2.04% |
| 2008 Q2 | -1.13 Million USD | 63.3% |
| 2007 Q4 | -3.01 Million USD | -4.78% |
| 2007 FY | -10.89 Million USD | -31.68% |
| 2007 Q3 | -2.88 Million USD | -16.56% |
| 2007 Q2 | -2.47 Million USD | 1.83% |
| 2007 Q1 | -2.51 Million USD | -3.37% |
| 2006 Q1 | -1.86 Million USD | 78.78% |
| 2006 FY | -8.27 Million USD | 35.56% |
| 2006 Q4 | -2.43 Million USD | -29.23% |
| 2006 Q3 | -1.88 Million USD | -3.67% |
| 2006 Q2 | -1.81 Million USD | 2.33% |
| 2005 Q3 | -1.61 Million USD | -41.03% |
| 2005 FY | -12.83 Million USD | -218.99% |
| 2005 Q2 | -1.14 Million USD | 11.66% |
| 2005 Q1 | -1.29 Million USD | -7.32% |
| 2005 Q4 | -8.77 Million USD | -442.23% |
| 2004 Q1 | -741.09 Thousand USD | -30.62% |
| 2004 FY | -4.02 Million USD | -99.34% |
| 2004 Q4 | -1.2 Million USD | -52.99% |
| 2004 Q3 | -790.82 Thousand USD | 38.3% |
| 2004 Q2 | -1.28 Million USD | -72.95% |
| 2003 FY | -2.01 Million USD | -3790.29% |
| 2003 Q1 | -338.29 Thousand USD | -1562.44% |
| 2003 Q3 | -548.55 Thousand USD | 2.77% |
| 2003 Q2 | -564.18 Thousand USD | -66.78% |
| 2003 Q4 | -567.36 Thousand USD | -3.43% |
| 2002 Q2 | -41.39 Thousand USD | -359.51% |
| 2002 FY | -51.88 Thousand USD | 73.81% |
| 2002 Q4 | -20.34 Thousand USD | -234.25% |
| 2002 Q3 | -6088.00 USD | 85.29% |
| 2002 Q1 | 15.95 Thousand USD | 119.5% |
| 2001 Q2 | -32.88 Thousand USD | 31.48% |
| 2001 Q1 | -47.98 Thousand USD | 2.82% |
| 2001 Q4 | -81.8 Thousand USD | -130.99% |
| 2001 FY | -198.08 Thousand USD | -15.77% |
| 2001 Q3 | -35.41 Thousand USD | -7.7% |
| 2000 Q4 | -49.38 Thousand USD | 26.05% |
| 2000 Q3 | -66.77 Thousand USD | -255.53% |
| 2000 Q2 | -18.78 Thousand USD | 48.06% |
| 2000 Q1 | -36.16 Thousand USD | 0.0% |
| 2000 FY | -171.1 Thousand USD | -491.08% |
| 1999 FY | 43.75 Thousand USD | 2376.0% |
| 1998 FY | 1767.00 USD | 102.53% |
| 1997 FY | -69.92 Thousand USD | -286.23% |
| 1996 FY | -18.1 Thousand USD | -2169.14% |
| 1995 FY | 875.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -715.597% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -55.979% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 120.559% |
| Nascent Biotech, Inc. | -2.08 Million USD | -421.715% |
| Rebus Holdings, Inc. | -1.02 Million USD | -967.818% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 116.722% |
| Qrons Inc. | -789.34 Thousand USD | -1279.842% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1622.268% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 82.601% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -2521.49% |
| Skye Bioscience, Inc. | -37.64 Million USD | 71.067% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 85.471% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -65.626% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -3883.782% |
| SQZ Biotechnologies Company | -79.46 Million USD | 86.293% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -276.565% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -498.274% |
| Mesoblast Limited | -87.95 Million USD | 87.617% |
| Marizyme, Inc. | -65.34 Million USD | 83.332% |
| Genus plc | 7.9 Million USD | 237.87% |
| Pharming Group N.V. | -10.54 Million USD | -3.259% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -401.967% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -193.559% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -23.154% |
| ContraFect Corporation | -65.15 Million USD | 83.283% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -122.914% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -530.508% |
| IMV Inc. | -36.48 Million USD | 70.148% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -35.139% |
| MultiCell Technologies, Inc. | -380.07 USD | -2865619.736% |
| ONE Bio Corp. | 8.67 Million USD | 225.53% |
| Accustem Sciences Inc. | -3.74 Million USD | -190.724% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 78.93% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -759.557% |
| Q BioMed Inc. | -2.05 Million USD | -430.763% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -191.769% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -357.469% |
| Biomind Labs Inc. | -1.21 Million USD | -796.942% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 81.764% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -251.146% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -37.816% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -458.766% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -72627.971% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 31.375% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -87.232% |
| GB Sciences, Inc. | -1.36 Million USD | -699.877% |
| Alpha Cognition Inc. | -13.77 Million USD | 20.917% |
| HST Global, Inc. | -146.21 Thousand USD | -7349.382% |
| CSL Limited | 2.64 Billion USD | 100.412% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -520.693% |
| Halberd Corporation | -79.67 Thousand USD | -13570.04% |
| Enzolytics Inc. | -2.17 Million USD | -400.348% |
| Agentix Corp. | -1.37 Million USD | -692.581% |
| Resverlogix Corp. | -3.61 Million USD | -201.71% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -243.432% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 96.309% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 11214.021% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 257.291% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -174.144% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -259.923% |
| AVAX Technologies, Inc. | -6.41 Million USD | -69.821% |
| Zenith Capital Corp. | -10.59 Million USD | -2.791% |
| Genscript Biotech Corporation | -95.47 Million USD | 88.592% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -46762.323% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -162.709% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -17920.568% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -443.198% |
| Kadimastem Ltd | -3.3 Million USD | -229.314% |
| Helix BioMedix, Inc. | -1.05 Million USD | -931.359% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -185.199% |
| BioStem Technologies, Inc. | -8.48 Million USD | -28.395% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -2367.718% |
| LadRx Corporation | 400.44 Thousand USD | 2819.923% |
| Cell Source, Inc. | -5.32 Million USD | -104.685% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1164.158% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1164.158% |
| NovAccess Global Inc. | -4.76 Million USD | -128.377% |
| Affymax, Inc. | -14.42 Million USD | 24.489% |
| Itoco Inc. | -1.86 Million USD | -482.759% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -145.17% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -552.591% |
| Mobile Lads Corp. | -2.26 Million USD | -381.234% |
| CytoDyn Inc. | -49.84 Million USD | 78.147% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -13681.257% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -4674.42% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1056.814% |
| SYBLEU INC | -180.3 Thousand USD | -5940.765% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -575.358% |
| International Stem Cell Corporation | -131 Thousand USD | -8214.306% |
| Bioxytran, Inc. | -4.28 Million USD | -154.48% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -19968.803% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -330.462% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 77.343% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -415.22% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1294.791% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -243.805% |
| Neutra Corp. | -233.46 Thousand USD | -4565.256% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 46.322% |
| PureTech Health plc | -65.69 Million USD | 83.421% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 48.785% |
| IXICO plc | -1.17 Million USD | -824.596% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -9.718% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 80.934% |
| CSL Limited | 2.64 Billion USD | 100.412% |
| Cellectis S.A. | -103.17 Million USD | 89.443% |